Personalized Medicine May Soon Hold True to Its Promise for Cancer Detection and Diagnosis…So Skeptics Beware

Stanley Lapidus, President and CEO of Helicos BioSciences, believes he has found the way to low-cost, high-throughput sequencing, a breakthrough technology in genetics. The advantage of doing single molecules is it allows you to do direct sequencing of the DNA from the tumor. The prep is simple; the reagents needed are minimal; and because of the single molecule design, the density can be quite high.